The Burden of Dyslipidemia and Determinant Factors Among Type 2 Diabetes Mellitus Patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia
Berhanu Kelemework,Kindie Woubshet,Sinetibeb Tadesse,Betelhem Eshetu,Dereje Geleta,Worku Ketema
DOI: https://doi.org/10.2147/dmso.s448350
2024-02-16
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Berhanu Kelemework, 1 Kindie Woubshet, 1 Sinetibeb Amsalu Tadesse, 1 Betelhem Eshetu, 2 Dereje Geleta, 2 Worku Ketema 3 1 Department of Internal Medicine, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia; 2 School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia; 3 Department of Pediatrics and Child Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia Correspondence: Worku Ketema, Department of Pediatrics and Child Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia, Email Background: Diabetes is a global health challenge with escalating prevalence rates. Cardiovascular complications represent the leading cause of mortality among individuals with diabetes. Notably, dyslipidemia stands as a prominent risk factor for cardiovascular disease in Type 2 diabetes mellitus (T2DM) patients. Timely detection and management of dyslipidemia in these patients hold the potential to deter its progression and substantially reduce the risk of cardiovascular-related morbidity and mortality. This study was aimed at assessing the burden of dyslipidemia and determinant factors among T2DM patients who were being followed at the Endocrinology clinic of Hawassa University Comprehensive Specialized Hospital (HUCSH). Methodology: An Institutional- based retrospective cross-sectional study was conducted, and samples of 228 patients were selected using a systematic random sampling technique. Data were collected through structured face-to-face interviews using a questionnaire. Bivariate logistic analysis was utilized, and variables with a p-value < 0.25 in this analysis were considered candidates for multivariate logistic analysis. Multivariate logistic regression was employed to identify factors associated with the prevalence of dyslipidemia, with a significance threshold set at p < 0.05. Results: The research revealed an overall prevalence of dyslipidemia among the study participants at 75.9%. The specific manifestations of dyslipidemia were observed as follows: hypertriglyceridemia in 43%, hypercholesterolemia in 25%, elevated low-density lipoprotein in 59.2%, and reduced high-density lipoprotein in 33.3% of the study participants. Factors significantly associated with dyslipidemia included longer diabetes duration, poor physical activity, elevated HbA1C, and obesity. Conclusion: This study underscores a notably high prevalence of dyslipidemia among T2DM patients. The findings highlight the advocate for clinicians to prioritize routine screening, and effective treatment concerning dyslipidemia and its associated risk factors among individuals with T2DM. It is worth mentioning that this study was conducted in a specific hospital setting and limited time, and hence the findings, and generalizability to other healthcare facilities should be taken cautiously. Keywords: T2DM, dyslipidemia, cardiovascular Diabetes mellitus, a metabolic disorder characterized by elevated serum glucose levels, affects over half a billion people globally. 1–3 The global prevalence of diabetes is projected to surge to 783 million by 2045, underscoring the urgent need for comprehensive management strategies. 4 Cardiovascular complications are a leading cause of diabetes-related morbidity and mortality, with dyslipidemia playing a central role. 4 Dyslipidemia, characterized by abnormal lipid levels, is implicated in over half of all cases of ischemic heart disease globally, resulting in millions of annual fatalities. 5 Sub-Saharan Africa faces a substantial burden, with dyslipidemia emerging as a critical cardiovascular risk factor. 6 Insulin resistance in Type 2 diabetes mellitus patients is a cornerstone in the genesis of dyslipidemia, involving multifaceted mechanisms. 7 Dyslipidemia is a major modifiable risk factor for cardiovascular disease, accounting for a significant portion of morbidity and mortality in the diabetic population. 8 Globally, dyslipidemia is responsible for approximately 4 million deaths and 29.7 million disability-adjusted life years, with increasing burdens due to factors such as reduced physical activity, prolonged diabetes duration, and obesity. 2,5,9 In Africa, high prevalence rates of dyslipidemia have been reported, highlighting its critical role as a cardiovascular risk factor. 10–12 In our country, the prevalence of dyslipidemia among diabetic individuals is also high, with major risk factors including hypertension, high BMI, aging, elevated fasting blood sugar levels, physical inactivity, and longer diabetes durati -Abstract Truncated-
endocrinology & metabolism